Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ase Bratland"'
Autor:
Michael Schenker, Mikhail Klochikhin, Ase Bratland, Dmitry Kirtbaya, Alexander Guminski, Marcin Dzienis, Chrysalyne Schmults, Joy Y. Ge, Jianda Yuan, Jenny Lee
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB135
Autor:
Åse Bratland, Eva Munoz-Couselo, Laurent Mortier, Osama Roshdy, Rene González, Jacob Schachter, Ana M. Arance, Florent Grange, Nicolas Meyer, Abhishek Jagdish Joshi, Salem Billan, Brett G. M. Hughes, Jean-Jacques Grob, Karthik Ramakrishnan, Joy Ge, Burak Gumuscu, Ramona F. Swaby, Ralf Gutzmer
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 12, Pp 3165-3180 (2023)
Abstract Introduction At first interim analysis of KEYNOTE-629, health-related quality of life (HRQoL) with pembrolizumab was stable or improved over 48 weeks in recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC). HRQoL results fr
Externí odkaz:
https://doaj.org/article/c25ae9485a674062bd066049630a8b43
Autor:
Øystein Fodstad, Wolfgang Lilleby, Piet J. Boender, Ase Bratland, Anne Hansen Ree, Mengyu Wang, Jens P. Berg, Hanne K. Høifødt, Rob Ruijtenbeek, Ingrid H.G. Østensen
Publikováno v:
Clinical & Experimental Metastasis. 26:485-496
Bone metastases in prostate cancer are predominantly osteoblastic. To study regulatory mechanisms underlying the establishment of prostate cancer within an osteoblastic microenvironment, human androgen-sensitive prostate carcinoma cells (LNCaP) were
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 128(2)
A diversity of cytotoxic and molecularly targeting agents are now offered for colorectal cancer; 5-fluorouracil was until recently the only available therapy. Molecular targeting agents inhibit cellular signalling mechanisms that govern tumour cell p
Autor:
Anne Hansen, Ree, Trond, Stokke, Ase, Bratland, Sebastian, Patzke, Ragnhild V, Nome, Sigurd, Folkvord, Leonardo A, Meza-Zepeda, Kjersti, Flatmark, Oystein, Fodstad, Yvonne, Andersson
Publikováno v:
Anticancer research. 26(3A)
In order to determine temporal responses of cell cycle populations to DNA damage, a rational combination of cell cycle analyses is critical. Moreover, the targeting of cell cycle checkpoint responses may modify the cytotoxic effect of DNA damage.The
Publikováno v:
Anticancer research. 24(2B)
Tumor cell cycle arrest at the cell cycle G2/M boundary after ionizing radiation involves inhibition of the Polo-like kinase 1 (Plk1). We recently found that the mechanism comprised repression of its gene, PLK, mediated by the tumor-suppressor protei
Autor:
Ase, Bratland, Erlend, Ragnhildstveit, Kristin, Bjørnland, Kristin, Andersen, Gunhild Mari, Maelandsmo, Oystein, Fodstad, Fahri, Saatcioglu, Anne Hansen, Ree
Publikováno v:
Clinicalexperimental metastasis. 20(6)
Tissue inhibitors of metalloproteinases (TIMPs) have been shown to perform several biological functions in tumor promotion, principally by their action of inhibiting matrix metalloproteinases (MMPs) at different steps of the metastatic process. In pa
Autor:
Anne Hansen, Ree, Ase, Bratland, Roger A, Kroes, Hans-Christian, Aasheim, Vivi A, Flørenes, Joseph R, Moskal, Oystein, Fodstad, Oyvind S, Bruland, Gunhild M, Maelandsmo
Publikováno v:
Anticancer research. 22(4)
Some cancers, particularly malignant melanomas and carcinomas of the breast and lung, metastasize to the central nervous system (CNS) in advanced stages. In order to develop into clinically manifest metastases, hematogenously disseminated tumor cells
Autor:
Marton König, Terje Osnes, Øyvind Bruland, Kirsten Sundby Hall, Åse Bratland, Torstein R. Meling
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Tumors originating from the craniofacial region usually present in a locally advanced stage with frequent involvement of adjacent sites and have a strong tendency for local recurrence in the absence of adjuvant therapy, even when the orig
Externí odkaz:
https://doaj.org/article/67408a96731e45d48fb3e4026f7c4979
Autor:
Kathrine Røe, Åse Bratland, Ljiljana Vlatkovic, Harald Bull Ragnum, Marie Grøn Saelen, Dag Rune Olsen, Laure Marignol, Anne Hansen Ree
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63723 (2013)
In this study, we hypothesized that androgen-deprivation therapy (ADT) in prostate cancer, although initially efficient, induces changes in the tumor kinome, which subsequently promote development of castration-resistant (CR) disease. Recognizing the
Externí odkaz:
https://doaj.org/article/17199364992041ea834ef7596d33118e